Emerging research suggest Retatru tide , a dual stimulator targeting both incretin and another hormone, appears to represent a significant advancement for obesity loss . Initial human investigations have demonstrated considerable decreases in abdominal tissue, potentially exceeding other body composition treatments. However , additional evaluation